Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Tauns Laboratories, Inc. ( (JP:197A) ) is now available.
TAUNS Laboratories, Inc. has decided to withdraw its application for a market classification change to the Prime Market of the Tokyo Stock Exchange due to delays in the review process and anticipated changes to the application content. The company maintains its intention to pursue this change at a more suitable time, and the withdrawal is expected to have minimal impact on its business operations or financial forecasts.
More about Tauns Laboratories, Inc.
TAUNS Laboratories, Inc. operates in the healthcare industry, focusing on the development and distribution of medical diagnostic products. The company is listed on the Tokyo Stock Exchange and aims to enhance its market presence by transitioning to the Prime Market.
Average Trading Volume: 581,674
Technical Sentiment Signal: Strong Buy
For detailed information about 197A stock, go to TipRanks’ Stock Analysis page.